Ai Mediq Asia

About Us

Our Company

Headquartered in Luxembourg, our mission is to advance non-invasive therapeutic solutions by leveraging the scientifically proven benefits of high-altitude (hypoxic) exposure. Through cutting-edge medical devices and personalized software algorithms, we deliver innovative Intermittent Hypoxic Treatments that improve health outcomes and enhance quality of life.

We are proud to be the original pioneers who commercialized the concept of short-term hypoxia adaptation for clinical practice. By harnessing the body’s natural physiological processes, we’ve set a new standard for innovative treatment approaches.

Our Commitment to Innovation

Since 2013, Ai Mediq has led advancements in medical technology through focused research and development efforts

Scientific Research

Exploring the effects of short-term, tailored hypoxic exposure on health and recovery in both healthy individuals and patients.

Demonstrating the efficacy of IHHT® in managing cardiovascular, pulmonary, cerebrovascular, and metabolic conditions.

 

Feasibility Studies
Establishing IHHT® and SRT® as effective, patient-friendly alternatives to traditional exercise-based cardiac rehabilitation.
 
 
 
 
 
 
 
Product Development
Designing and prototyping state-of-the-art medical devices to meet evolving healthcare needs.
 
 
 
 
 
 
 
 

With innovation, collaboration, and a passion for improving lives, Ai Mediq Asia continues to push the boundaries of medical technology.

ReOxy®

is the sole device in its class with benefits demonstrated in clinical studies

Partner with us to bring intelligent therapy to your community.

Breathe. Live Better

Reach out to us or learn more about ReOxy®